• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAXTER HEALTHCARE CORPORATION INTRAVIA; CONTAINER, I.V.

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAXTER HEALTHCARE CORPORATION INTRAVIA; CONTAINER, I.V. Back to Search Results
Model Number 2B8013
Medical Device Problem Code Device Contamination with Chemical or Other Material (2944)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 03/27/2025
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
E1: initial reporter address: (b)(6).Should additional relevant information become available, a supplemental report will be submitted.
 
Event or Problem Description
It was reported that an empty 500 ml capacity intravia container had particulate in the solution.The particulate was a large solid white plastic looking particulate.The particulate best matched the interior surface of the bag septum.This was observed prior to patient use.There was no patient involvement.No additional information is available.
 
Additional Manufacturer Narrative
Additional information was added to h4, h6, and h11: h11: the actual device was not available; however, photographs of the sample were provided for evaluation.A visual inspection was performed, and a little particle in the bag was observed.The reported condition was verified.The cause of the condition could not be determined.A batch review was conducted and there were no deviations found related to this reported condition during the manufacture of this lot.Should additional relevant information become available, a supplemental report will be submitted.
 
Additional Manufacturer Narrative
Additional information was added to h11: h11: the ir spectrum of the particles best matches the interior surface of a baxter intravia bag septum at approximately 88.8%.It is likely that this pm comes from the membrane in the administration port of the bag.Should additional relevant information become available, a supplemental report will be submitted.
 
Additional Manufacturer Narrative
Correction: h6 (codes for investigation findings and investigation conclusions were corrected).Additional information was added to h11: the device analysis was performed by a non-baxter lab.The cause of the issue was due to material supplier related to manufacturing.Should additional relevant information become available, a supplemental report will be submitted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
INTRAVIA
Common Device Name
CONTAINER, I.V.
Manufacturer (Section D)
BAXTER HEALTHCARE CORPORATION
deerfield IL
Manufacturer (Section G)
BAXTER HEALTHCARE - HAINA
piisa industrial park antigua
carretera sanchez km 18 1/2
haina, san cristobal 91000
DR   91000
Manufacturer Contact
25212 w. illinois route 120
round lake, IL 60073
2242702068
MDR Report Key22023299
Report Number1416980-2025-02851
Device Sequence Number8734050
Product Code KPE
UDI-Device Identifier00085412035260
UDI-Public(01)00085412035260(10)DR24E31055
Combination Product (Y/N)N
Initial Reporter StateTX
Initial Reporter CountryUS
PMA/510(K) Number
K964853
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Company Representative
Initial Reporter Occupation Other
Type of Report Initial,Followup,Followup,Followup
Report Date (Section B) 03/20/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Other
Device Model Number2B8013
Device Catalogue Number2B8013
Device Lot NumberDR24E31055
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 04/23/2025
Supplement Date Received by Manufacturer06/13/2025
02/19/2026
02/19/2026
Initial Report FDA Received Date05/14/2025
Supplement Report FDA Received Date06/18/2025
02/26/2026
03/20/2026
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured06/03/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-